Uncategorized

September 24, 2018

The Financial Impact of Strategic Innovation

Market intel firm CB Insights recently published results from its survey of corporate strategy executives, illustrating the fact that 41% of executives say their firms are extremely at risk, or very at risk of disruption.  Perhaps no other industry is more vulnerable to disruption than medical device. Let’s explore the confluence of market drivers that medical device companies face: Demographics – U.S. populations are growing older and living longer. Prevalence of Chronic Conditions – According […]
August 28, 2018

The Coming Age of Strategic Innovation in Medical Device

Efficient and effective engineering and new device development have always been central to the success of medical device companies.  Under the traditional, Fee-For-Service reimbursement landscape, companies could identify costly or marginally effective procedures and develop products that improved patient outcomes while lowering the current cost of care.  As medical device companies evolved, many developed a particular rhythm to the development and commercialization process.  In the past, I’ve worked with device companies that actually held off […]
June 19, 2018

REV•1 Engineering To Speak at Drug/Device Combination Product Summit

Phil Burke to Present “Best Practices” for Device Development with Drug/Device Combination Products at Boston Summit. MURRIETA, Calif. – June 19, 2018 – (FOR IMMEDIATE RELEASE) — REV•1 Engineering will be presenting “Accelerating Along the Critical Path – Identifying Best Practices for De-Risking Device Development for Combination Products” at the Combination Product Life Cycle Management Summit in Boston, MA, June 19th – 21st. Combination products integrate a medical device for the delivery of a therapeutic drug.  Examples can be […]
X
Schedule a Conversation
Contact Us